Gruenberg Marcelo, Mereles Maximiliano E, Willhuber Gastón O Camino, Valacco Marcelo, Petracchi Matias G, Solá Carlos A
Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Global Spine J. 2017 May;7(3):260-265. doi: 10.1177/2192568217699186. Epub 2017 Apr 11.
Retrospective study.
Spinal metastasis can produce pain, deformity, neurological compromise and can decrease life expectancy. Surgical management is usually indicated for pain control, neurological decompression, and to avoid deformity progression. Tokuhashi et al created a scoring system to estimate survival and stratify surgical treatment based on established parameters. Our objective was to evaluate the usefulness of Tokuhashi scoring (TS) system by comparing the predicted and real survival times and analyze the survival time according to the type of tumor.
From 2004 to 2014, 105 patients with vertebral metastasis who underwent surgical treatment were enrolled and retrospectively analyzed. Preoperative TS was performed in all cases. Patients were classified into 3 groups according to TS; group 1 (TS 0-8), group 2 (TS 9-11), and group 3 (TS 12-15). Patients' average age was 61.5 years, main primary tumor site were as follows: kidney (23%), lung (19%), and breast (18%).
The Tokuhashi general concordance was 67.6%. Per group concordance was as follows: group 1 80%, in group 2, only 33% of concordance was observed. In group 3, 100% of concordance was observed. In group 2, the most common primary sites were breast and kidney and the mean survival was 20 and 22.3 months, respectively, both longer than that expected for this group.
Tokuhashi concordance was acceptable in our study, particularly in lower and higher scores. The lesser concordance observed in group 2 (33.3%) was observed in almost all tumors. For our practice, TS constitutes an acceptable tool to define survival, particularly in lower and higher scores.
回顾性研究。
脊柱转移瘤可导致疼痛、畸形、神经功能障碍,并可缩短预期寿命。手术治疗通常用于控制疼痛、解除神经压迫以及避免畸形进展。Tokuhashi等人创建了一个评分系统,以根据既定参数估计生存率并对手术治疗进行分层。我们的目的是通过比较预测生存时间和实际生存时间来评估Tokuhashi评分(TS)系统的实用性,并根据肿瘤类型分析生存时间。
纳入2004年至2014年期间接受手术治疗的105例脊柱转移瘤患者,并进行回顾性分析。所有病例均在术前进行TS评分。根据TS评分将患者分为3组;第1组(TS 0 - 8),第2组(TS 9 - 11),第3组(TS 12 - 15)。患者的平均年龄为61.5岁,主要原发肿瘤部位如下:肾脏(23%)、肺(19%)和乳腺(18%)。
Tokuhashi总体一致性为67.6%。每组的一致性如下:第1组为80%,在第2组中,仅观察到33%的一致性。在第3组中,观察到100%的一致性。在第2组中,最常见的原发部位是乳腺和肾脏,平均生存期分别为20个月和22.3个月,均长于该组预期生存期。
在我们的研究中,Tokuhashi一致性是可以接受的,特别是在低分和高分情况下。在第2组中观察到的较低一致性(33.3%)在几乎所有肿瘤中都有出现。对于我们的实践而言,TS评分是定义生存情况的一个可接受工具,特别是在低分和高分情况下。